ClinConnect ClinConnect Logo
Search / Trial NCT06961877

Skills for Talking About Cannabis for Families of Young Adults With Psychosis

Launched by UNIVERSITY OF WASHINGTON · May 5, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Coordinated Specialty Care Cannabis Use Disorder First Episode Psychosis Caregiver Burden Cannabis Use Communication Skills

ClinConnect Summary

This clinical trial aims to help families of young adults who are dealing with psychosis and heavy cannabis use. The researchers want to create a program that teaches family members better communication skills so they can support their loved ones in reducing cannabis use. They will first test this program with a small group of 10 family members, gather their feedback, and then run a larger pilot study with 40 participants to see how well the program works. The goal is to improve family communication, reduce stress for caregivers, and ultimately help young adults use less cannabis.

To participate in this study, family members need to be at least 18 years old and have a loved one who is receiving treatment for a first episode of psychosis and has used cannabis frequently in the past month. It's important that they spend at least 10 hours a week with this person. Participants should be comfortable using Zoom for meetings and able to read study materials in English. The trial is not yet recruiting, but it could be a valuable opportunity for families looking for support in managing cannabis use and improving communication within the family.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. aged 18 years or older,
  • 2. has a loved one who is both in CSC treatment for FEP and has used cannabis on at least 9 days in the past 30,
  • 3. has at least 10 hours of contact per week with their loved one with FEP. It is assumed that YA-P will be aged 13-40 with schizophrenia spectrum disorder given criteria for CSC enrollment.
  • Exclusion Criteria:
  • 1. Unable to read study materials and communicate feedback in English
  • 2. Do not have access to Zoom

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Denise Walker, Ph.D.

Principal Investigator

University of Washington

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported